![Diabetes Drug Reduces Weight Gain in Obese Pregnant Women | CardioSmart – American College of Cardiology Diabetes Drug Reduces Weight Gain in Obese Pregnant Women | CardioSmart – American College of Cardiology](https://www.cardiosmart.org/images/default-source/news-article-images/95661220.tmb-dtl-news-a.jpg?sfvrsn=780dd168_2)
Diabetes Drug Reduces Weight Gain in Obese Pregnant Women | CardioSmart – American College of Cardiology
![Microbial Imidazole Propionate Affects Responses to Metformin through p38γ-Dependent Inhibitory AMPK Phosphorylation - ScienceDirect Microbial Imidazole Propionate Affects Responses to Metformin through p38γ-Dependent Inhibitory AMPK Phosphorylation - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1550413120303703-fx1.jpg)
Microbial Imidazole Propionate Affects Responses to Metformin through p38γ-Dependent Inhibitory AMPK Phosphorylation - ScienceDirect
![Metformin in obese pregnancy has no adverse effects on cardiovascular risk in early childhood | Journal of Developmental Origins of Health and Disease | Cambridge Core Metformin in obese pregnancy has no adverse effects on cardiovascular risk in early childhood | Journal of Developmental Origins of Health and Disease | Cambridge Core](https://static.cambridge.org/binary/version/id/urn:cambridge.org:id:binary:20210616144108575-0265:S2040174421000301:S2040174421000301_tab2.png?pub-status=live)
Metformin in obese pregnancy has no adverse effects on cardiovascular risk in early childhood | Journal of Developmental Origins of Health and Disease | Cambridge Core
![Effect of metformin in addition to an antenatal diet and lifestyle intervention on fetal growth and adiposity: the GRoW randomised trial | BMC Endocrine Disorders | Full Text Effect of metformin in addition to an antenatal diet and lifestyle intervention on fetal growth and adiposity: the GRoW randomised trial | BMC Endocrine Disorders | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12902-020-00618-0/MediaObjects/12902_2020_618_Fig1_HTML.png)
Effect of metformin in addition to an antenatal diet and lifestyle intervention on fetal growth and adiposity: the GRoW randomised trial | BMC Endocrine Disorders | Full Text
![Metformin Therapy During Pregnancy: Good for the goose and good for the gosling too? – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka Metformin Therapy During Pregnancy: Good for the goose and good for the gosling too? – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka](https://cyberleninka.org/viewer_images/188958/f/1.png)
Metformin Therapy During Pregnancy: Good for the goose and good for the gosling too? – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka
![Frontiers | GDF-15 as a Weight Watcher for Diabetic and Non-Diabetic People Treated With Metformin | Endocrinology Frontiers | GDF-15 as a Weight Watcher for Diabetic and Non-Diabetic People Treated With Metformin | Endocrinology](https://www.frontiersin.org/files/Articles/581839/fendo-11-581839-HTML/image_m/fendo-11-581839-g001.jpg)
Frontiers | GDF-15 as a Weight Watcher for Diabetic and Non-Diabetic People Treated With Metformin | Endocrinology
![Metformin in obese pregnancy has no adverse effects on cardiovascular risk in early childhood | Journal of Developmental Origins of Health and Disease | Cambridge Core Metformin in obese pregnancy has no adverse effects on cardiovascular risk in early childhood | Journal of Developmental Origins of Health and Disease | Cambridge Core](https://static.cambridge.org/binary/version/id/urn:cambridge.org:id:binary:20210616144108575-0265:S2040174421000301:S2040174421000301_fig1.png?pub-status=live)
Metformin in obese pregnancy has no adverse effects on cardiovascular risk in early childhood | Journal of Developmental Origins of Health and Disease | Cambridge Core
![Addition of either pioglitazone or a sulfonylurea in type 2 diabetic patients inadequately controlled with metformin alone: Impact on cardiovascular events. A randomized controlled trial - Nutrition, Metabolism and Cardiovascular Diseases Addition of either pioglitazone or a sulfonylurea in type 2 diabetic patients inadequately controlled with metformin alone: Impact on cardiovascular events. A randomized controlled trial - Nutrition, Metabolism and Cardiovascular Diseases](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2003889018/2015646527/gr1.jpg)
Addition of either pioglitazone or a sulfonylurea in type 2 diabetic patients inadequately controlled with metformin alone: Impact on cardiovascular events. A randomized controlled trial - Nutrition, Metabolism and Cardiovascular Diseases
![PDF) Association between insulin resistance and preeclampsia in obese non-diabetic women receiving metformin PDF) Association between insulin resistance and preeclampsia in obese non-diabetic women receiving metformin](https://i1.rgstatic.net/publication/320430397_Association_between_insulin_resistance_and_preeclampsia_in_obese_non-diabetic_women_receiving_metformin/links/59f7c3a2aca272607e2d8ce1/largepreview.png)
PDF) Association between insulin resistance and preeclampsia in obese non-diabetic women receiving metformin
![Comment on Koivusalo et al. Gestational Diabetes Mellitus Can Be Prevented by Lifestyle Intervention: The Finnish Gestational Diabetes Prevention Study (RADIEL): A Randomized Controlled Trial. Diabetes Care 2016;39:24–30 | Diabetes Care Comment on Koivusalo et al. Gestational Diabetes Mellitus Can Be Prevented by Lifestyle Intervention: The Finnish Gestational Diabetes Prevention Study (RADIEL): A Randomized Controlled Trial. Diabetes Care 2016;39:24–30 | Diabetes Care](https://care.diabetesjournals.org/sites/default/files/highwire/diacare/39/8.cover-source.jpg)
Comment on Koivusalo et al. Gestational Diabetes Mellitus Can Be Prevented by Lifestyle Intervention: The Finnish Gestational Diabetes Prevention Study (RADIEL): A Randomized Controlled Trial. Diabetes Care 2016;39:24–30 | Diabetes Care
![Metformin in obese pregnancy has no adverse effects on cardiovascular risk in early childhood | Journal of Developmental Origins of Health and Disease | Cambridge Core Metformin in obese pregnancy has no adverse effects on cardiovascular risk in early childhood | Journal of Developmental Origins of Health and Disease | Cambridge Core](https://static.cambridge.org/binary/version/id/urn:cambridge.org:id:binary:20210616144108575-0265:S2040174421000301:S2040174421000301_tab3.png?pub-status=live)
Metformin in obese pregnancy has no adverse effects on cardiovascular risk in early childhood | Journal of Developmental Origins of Health and Disease | Cambridge Core
![Metformin in gestational diabetes: An emerging contender – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open science hub. Metformin in gestational diabetes: An emerging contender – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open science hub.](https://cyberleninka.org/viewer_images/1044003/f/1.png)
Metformin in gestational diabetes: An emerging contender – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open science hub.
![Use of metformin to treat pregnant women with polycystic ovary syndrome (PregMet2): a randomised, double-blind, placebo-controlled trial - The Lancet Diabetes & Endocrinology Use of metformin to treat pregnant women with polycystic ovary syndrome (PregMet2): a randomised, double-blind, placebo-controlled trial - The Lancet Diabetes & Endocrinology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/3705bc47-7921-4c1b-8878-d96df55e3af9/gr1.gif)
Use of metformin to treat pregnant women with polycystic ovary syndrome (PregMet2): a randomised, double-blind, placebo-controlled trial - The Lancet Diabetes & Endocrinology
![Efficacy and safety of metformin during pregnancy in women with gestational diabetes mellitus or polycystic ovary syndrome: A systematic review - Metabolism - Clinical and Experimental Efficacy and safety of metformin during pregnancy in women with gestational diabetes mellitus or polycystic ovary syndrome: A systematic review - Metabolism - Clinical and Experimental](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2009089752/2031159386/gr1.jpg)
Efficacy and safety of metformin during pregnancy in women with gestational diabetes mellitus or polycystic ovary syndrome: A systematic review - Metabolism - Clinical and Experimental
![Effect of metformin in addition to dietary and lifestyle advice for pregnant women who are overweight or obese: the GRoW randomised, double-blind, placebo-controlled trial - The Lancet Diabetes & Endocrinology Effect of metformin in addition to dietary and lifestyle advice for pregnant women who are overweight or obese: the GRoW randomised, double-blind, placebo-controlled trial - The Lancet Diabetes & Endocrinology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/152bb3a5-a791-4133-92bc-163e2882f067/gr1_lrg.gif)